FAS
Tumor necrosis factor receptor superfamily member 6
Also known as: APO-1, APT1, CD95, FAS1, TNFRSF6, TNR6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P25445
- Gene
- FAS
- Ensembl
- ENSG00000026103
- Chromosome
- 10
- Canonical length
- 335 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
- Subcellular location
- Nuclear bodies,Plasma membrane,Cytosol
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains a death domain. It has been shown to play a central role in the physiological regulation of programmed cell death, and has been implicated in the pathogenesis of various malignancies and diseases of the immune system. The interaction of this receptor with its ligand allows the formation of a death-inducing signaling complex that includes Fas-associated death domain protein (FADD), caspase 8, and caspase 10. The autoproteolytic processing of the caspases in the complex triggers a downstream caspase cascade, and leads to apoptosis. This receptor has been also shown to activate NF-kappaB, MAPK3/ERK1, and MAPK8/JNK, and is found to be involved in transducing the proliferating signals in normal diploid fibroblast and T cells. Several alternatively spliced transcript variants have been described, some of which are candidates for nonsense-mediated mRNA decay (NMD). The isoforms lacking the transmembrane domain may negatively regulate the apoptosis mediated by the full length isoform. [provided by RefSeq, Mar 2011]
Canonical amino-acid sequenceUniProt
335 residues, UniProt reviewed canonical sequence.
>P25445|FAS
1 MLGIWTLLPL VLTSVARLSS KSVNAQVTDI NSKGLELRKT VTTVETQNLE GLHHDGQFCH
61 KPCPPGERKA RDCTVNGDEP DCVPCQEGKE YTDKAHFSSK CRRCRLCDEG HGLEVEINCT
121 RTQNTKCRCK PNFFCNSTVC EHCDPCTKCE HGIIKECTLT SNTKCKEEGS RSNLGWLCLL
181 LLPIPLIVWV KRKEVQKTCR KHRKENQGSH ESPTLNPETV AINLSDVDLS KYITTIAGVM
241 TLSQVKGFVR KNGVNEAKID EIKNDNVQDT AEQKVQLLRN WHQLHGKKEA YDTLIKDLKK
301 ANLCTLAEKI QTIILKDITS DSENSNFRNE IQSLVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- lung: 16 nTPM
- ovary: 15 nTPM
- adrenal gland: 14 nTPM
- liver: 12 nTPM
- bone marrow: 11 nTPM
- adipose tissue: 9 nTPM
Single-cell type
- neutrophils: 161 nCPM
- epididymal basal cells: 144 nCPM
- fallopian secretory cells: 108 nCPM
- mesothelial cells: 107 nCPM
- alveolar cells type 1: 104 nCPM
- epicardial cells: 96 nCPM
Immune cell
- neutrophil: 101 nTPM
- T-reg: 91 nTPM
- basophil: 41 nTPM
- eosinophil: 32 nTPM
- memory CD4 T-cell: 25 nTPM
- memory CD8 T-cell: 21 nTPM
Brain region
- medulla oblongata: 8.8 nTPM
- cerebral cortex: 7.5 nTPM
- white matter: 7.4 nTPM
- amygdala: 7 nTPM
- pons: 7 nTPM
- thalamus: 7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FAS.
Disease | AllUniProt
Conditions FAS is implicated in, by any mechanism.
- Autoimmune lymphoproliferative syndrome 1A (ALPS1A) MIM:601859
Disease | GeneticClinVar
119 pathogenic / likely-pathogenic of 518 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autoimmune lymphoproliferative syndrome type 1
- FAS-related autoimmune lymphoproliferative syndrome
- SQUAMOUS CELL CARCINOMA, BURN SCAR-RELATED, SOMATIC
- FAS-related disorder
- Autoimmune lymphoproliferative syndrome with defective apoptosis
ReferencesPubMed · IEDB
Publications for FAS from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
12 publications
- Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations.
2003 · J Allergy Clin Immunol · RCR 1.5 · 69 citations - FAS engagement drives apoptosis of enterocytes of coeliac patients.
2001 · Gut · RCR 1.4 · 63 citations - The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations.
1999 · Arthritis Rheum · RCR 1.3 · 70 citations - The effect of LPS on neutrophils from patients with high risk of type 1 diabetes mellitus in relation to IL-8, IL-10 and IL-12 production and apoptosis in vitro.
2002 · Scand J Immunol · RCR 0.6 · 27 citations - Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
1998 · Cell Death Differ · RCR 0.4 · 18 citations
Show 7 more
- Evidence for autoantibody-induced CD4 depletion mediated by apoptotic and non-apoptotic mechanisms in HIV-positive long-term surviving haemophilia patients.
2004 · Clin Exp Immunol · RCR 0.2 · 11 citations - CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses.
1998 · J Immunol · RCR 0.2 · 12 citations - CD95-Mediated control of anti-citrullinated protein/peptides antibodies (ACPA)-producing plasma cells occurring in rheumatoid arthritis inflamed joints.
2007 · Rheumatology (Oxford) · RCR 0.2 · 8 citations - Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
1998 · J Immunol · RCR 0.1 · 8 citations - [CD95 (APO-1/Fas) and CD95-ligand (CD95L). Implications of these apoptosis mediating receptor/ligand systems in the pathogenesis of autoimmune diseases].
1996 · Verh Dtsch Ges Pathol · RCR 0.1 · 5 citations - The role of pathogenic B-cell clones in antibody mediated autoimmune disorders.
2004 · J Dermatol Sci · RCR 0.1 · 3 citations - Activation, Isolation, and Analysis of the Death-Inducing Signaling Complex.
2015 · Cold Spring Harb Protoc · RCR 0.1 · 2 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.81
- gnomAD missense Z
- 1.23
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation-induced cell death of T cells
- apoptotic process
- cellular response to amino acid starvation
- cellular response to hyperoxia
- cellular response to mechanical stimulus
- extrinsic apoptotic signaling pathway
- extrinsic apoptotic signaling pathway via death domain receptors
- Fas signaling pathway
- immune response
- motor neuron apoptotic process
- necroptotic signaling pathway
- negative regulation of apoptotic process
- positive regulation of apoptotic process
- positive regulation of apoptotic signaling pathway
- positive regulation of reactive oxygen species biosynthetic process
- protein-containing complex assembly
- regulation of apoptotic process
- regulation of stress-activated MAPK cascade
- signal transduction
Molecular functions
- calmodulin binding
- identical protein binding
- kinase binding
- signaling receptor activity
- tumor necrosis factor receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Death domain
- TNFR/NGFR cysteine-rich region
- Death-like domain superfamily
- TNFR/NGFR cysteine-rich region
- Death domain
- Fas receptor
- Fas receptor, death domain
- Fas receptor, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FAS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAS as an antibody target. Whether an autoantibody or antibody against FAS could matter depends on whether native FAS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAS is annotated at the cell surface, where native FAS is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FAS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...